Inner Mongolia Furui Medical Science Co., Ltd.

SZSE:300049 Stock Report

Market Cap: CN¥9.4b

Inner Mongolia Furui Medical Science Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Guanyi Wang

Chief executive officer

CN¥300.0k

Total compensation

CEO salary percentagen/a
CEO tenure1.6yrs
CEO ownership11.3%
Management average tenureno data
Board average tenure4.6yrs

Recent management updates

Recent updates

Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Dec 18
Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%

Oct 17
Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%

Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Sep 02
Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

Jul 21
Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

May 24
With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Apr 29
We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Feb 28
Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

CEO

Guanyi Wang (54 yo)

1.6yrs

Tenure

CN¥300,000

Compensation

Mr. Guanyi Wang serves as the Chairman of Inner Mongolia Free Han & Mongolia Pharmaceutical Co. Ltd and serves as its General Manager since May 17, 2023.


Board Members

NamePositionTenureCompensationOwnership
Guanyi Wang
GM & Chairmanno dataCN¥300.00k11.3%
CN¥ 1.1b
Yong Yang
Deputy GM & Director4.6yrsCN¥783.00k0.089%
CN¥ 8.4m
Lijuan Deng
Deputy GM & Director4.6yrsCN¥1.02m0.038%
CN¥ 3.5m
Li Qun Wang
Chairman of the Supervisory Board13.8yrsCN¥60.00k0.041%
CN¥ 3.8m
Jinlong Guo
Independent Director4.6yrsCN¥60.00kno data
Fangyuan Geng
Independent Director4.6yrsCN¥60.00kno data
Dandan Wang
Employee Representative Supervisor4.6yrsno data0.021%
CN¥ 2.0m
Hao Chen
Non-Employee Representative Supervisor4.6yrsno datano data
Ru Wang
Employee Representative Supervisor7.7yrsno datano data
Lang Tian
Employee Representative Supervisor3.7yrsno datano data
Zhe Li
Non-Independent Director1.6yrsno datano data
Peng Guo
Independent Director2.6yrsCN¥60.00kno data

4.6yrs

Average Tenure

51.5yo

Average Age

Experienced Board: 300049's board of directors are considered experienced (4.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 22:42
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Inner Mongolia Furui Medical Science Co., Ltd. is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chen HeChasing Securities
Shitong HanCitic Securities Co., Ltd.
Siao YeEverbright Securities Co. Ltd.